These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7826902)

  • 1. Drug immunotargeting for carcinomas: a reality at last?
    Casazza AM; Trail PA; Hellström KE
    Ann Oncol; 1994 Oct; 5(8):703-8. PubMed ID: 7826902
    [No Abstract]   [Full Text] [Related]  

  • 2. Cure of xenografted human carcinomas by BR96-doxorubicin immunoconjugates.
    Trail PA; Willner D; Lasch SJ; Henderson AJ; Hofstead S; Casazza AM; Firestone RA; Hellström I; Hellström KE
    Science; 1993 Jul; 261(5118):212-5. PubMed ID: 8327892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher efficiency of 131I-labeled anti-carcinoembryonic antigen-monoclonal antibody F(ab')2 as compared to intact antibodies in radioimmunotherapy of established human colon carcinoma grafted in nude mice.
    Buchegger F; Mach JP; Folli S; Delaloye B; Bischof-Delaloye A; Pèlegrin A
    Recent Results Cancer Res; 1996; 141():19-35. PubMed ID: 8722418
    [No Abstract]   [Full Text] [Related]  

  • 4. Monoclonal antibody Po66 uptake by human lung tumours implanted in nude mice: effect of co-administration with doxorubicin.
    Desrues B; Léna H; Brichory F; Ramée MP; Toujas L; Delaval P; Dazord L
    Br J Cancer; 1995 Nov; 72(5):1076-82. PubMed ID: 7577450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibody gene transfer. Implications for tumor-specific cell-mediated cytotoxicity.
    Primus FJ; Finch MD; Wetzel SA; Masci AM; Schlom J; Kashmiri SV
    Ann N Y Acad Sci; 1994 May; 716():154-65; discussion 165-6. PubMed ID: 8024192
    [No Abstract]   [Full Text] [Related]  

  • 6. Potential clinical utility of monoclonal antibodies in the management of human carcinomas.
    Schlom J; Weeks MO
    Important Adv Oncol; 1985; ():170-92. PubMed ID: 3916739
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of growth of colorectal carcinoma in nude mice by monoclonal antibody.
    Herlyn DM; Steplewski Z; Herlyn MF; Koprowski H
    Cancer Res; 1980 Mar; 40(3):717-21. PubMed ID: 7471090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioimmunotherapy of nude mice with intraperitoneally growing ovarian cancer xenograft utilizing 211At-labelled monoclonal antibody MOv18.
    Andersson H; Lindegren S; Back T; Jacobsson L; Leser G; Horvath G
    Anticancer Res; 2000; 20(1A):459-62. PubMed ID: 10769696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoconjugates: lessons from animal models.
    Canevari S; Colombatti M; Colnaghi MI
    Ann Oncol; 1994 Oct; 5(8):698-701. PubMed ID: 7826901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen-specific activity of carcinoma-reactive BR64-doxorubicin conjugates evaluated in vitro and in human tumor xenograft models.
    Trail PA; Willner D; Lasch SJ; Henderson AJ; Greenfield RS; King D; Zoeckler ME; Braslawsky GR
    Cancer Res; 1992 Oct; 52(20):5693-700. PubMed ID: 1382845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anthracycline immunoconjugates prepared by a site-specific linkage via an amino-dextran intermediate carrier.
    Shih LB; Goldenberg DM; Xuan H; Lu H; Sharkey RM; Hall TC
    Cancer Res; 1991 Aug; 51(16):4192-8. PubMed ID: 1868440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of linker variation on the stability, potency, and efficacy of carcinoma-reactive BR64-doxorubicin immunoconjugates.
    Trail PA; Willner D; Knipe J; Henderson AJ; Lasch SJ; Zoeckler ME; TrailSmith MD; Doyle TW; King HD; Casazza AM; Braslawsky GR; Brown J; Hofstead SJ; Greenfield RS; Firestone RA; Mosure K; Kadow KF; Yang MB; Hellström KE; Hellström I
    Cancer Res; 1997 Jan; 57(1):100-5. PubMed ID: 8988048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination radioimmunotherapy with local hyperthermia: increased delivery of radioimmunoconjugate by vascular effect and its retention by increased antigen expression in colon cancer xenografts.
    Kinuya S; Yokoyama K; Hiramatsu T; Tega H; Tanaka K; Konishi S; Shuke N; Aburano T; Watanabe N; Takayama T; Michigishi T; Tonami N
    Cancer Lett; 1999 Jun; 140(1-2):209-18. PubMed ID: 10403561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful radioimmunotherapy for lung metastasis of human colonic cancer in nude mice.
    Sharkey RM; Weadock KS; Natale A; Haywood L; Aninipot R; Blumenthal RD; Goldenberg DM
    J Natl Cancer Inst; 1991 May; 83(9):627-32. PubMed ID: 1708835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of seven new vasoactive immunoconjugates on the enhancement of monoclonal antibody uptake in tumors.
    Khawli LA; Miller GK; Epstein AL
    Cancer; 1994 Feb; 73(3 Suppl):824-31. PubMed ID: 8306266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can preirradiation enhance tumor uptake of radiolabeled pharmaceuticals? Experimental data in a mouse neuroblastoma xenograft system.
    Sautter-Bihl ML; Bihl H
    Recent Results Cancer Res; 1996; 141():123-35. PubMed ID: 8722423
    [No Abstract]   [Full Text] [Related]  

  • 17. Antitumor activity of carcinoma-reactive BR96-doxorubicin conjugate against human carcinomas in athymic mice and rats and syngeneic rat carcinomas in immunocompetent rats.
    Sjögren HO; Isaksson M; Willner D; Hellström I; Hellström KE; Trail PA
    Cancer Res; 1997 Oct; 57(20):4530-6. PubMed ID: 9377565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ablation of human colon carcinoma in nude mice by 131I-labeled monoclonal anti-carcinoembryonic antigen antibody F(ab')2 fragments.
    Buchegger F; Pfister C; Fournier K; Prevel F; Schreyer M; Carrel S; Mach JP
    J Clin Invest; 1989 May; 83(5):1449-56. PubMed ID: 2708519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of tumor growth inhibition.
    Steplewski Z; Herlyn D; Lubeck M; Kimoto Y; Herlyn M; Koprowski H
    Hybridoma; 1986 Jul; 5 Suppl 1():S59-64. PubMed ID: 3744386
    [No Abstract]   [Full Text] [Related]  

  • 20. In vivo evaluation of a lead-labeled monoclonal antibody using the DOTA ligand.
    Milenic DE; Roselli M; Brechbiel MW; Pippin CG; McMurray TJ; Carrasquillo JA; Colcher D; Lambrecht R; Gansow OA; Schlom J
    Eur J Nucl Med; 1998 May; 25(5):471-80. PubMed ID: 9575242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.